188 related articles for article (PubMed ID: 35454175)
21. Caspase-dependent cleavage of cadherins and catenins during osteoblast apoptosis.
Hunter I; McGregor D; Robins SP
J Bone Miner Res; 2001 Mar; 16(3):466-77. PubMed ID: 11277264
[TBL] [Abstract][Full Text] [Related]
22. A Clinicopathologic Analysis of 207 Cases of Benign Fibro-Osseous Lesions of the Jaws.
Phattarataratip E; Pholjaroen C; Tiranon P
Int J Surg Pathol; 2014 Jun; 22(4):326-33. PubMed ID: 24326826
[TBL] [Abstract][Full Text] [Related]
23. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
24. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
[TBL] [Abstract][Full Text] [Related]
25. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
[TBL] [Abstract][Full Text] [Related]
26. Microtubule actin crosslinking factor 1 promotes osteoblast differentiation by promoting β-catenin/TCF1/Runx2 signaling axis.
Hu L; Su P; Yin C; Zhang Y; Li R; Yan K; Chen Z; Li D; Zhang G; Wang L; Miao Z; Qian A; Xian CJ
J Cell Physiol; 2018 Feb; 233(2):1574-1584. PubMed ID: 28621459
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.
Xu B; Sano T; Yoshimoto K; Yamada S
Endocr Pathol; 2002; 13(4):341-51. PubMed ID: 12665652
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs.
Alves Pereira KM; do Amaral BA; dos Santos BR; Galvão HC; Freitas Rde A; de Souza LB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):425-31. PubMed ID: 20219600
[TBL] [Abstract][Full Text] [Related]
29. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31.
Szabó J; Heath B; Hill VM; Jackson CE; Zarbo RJ; Mallette LE; Chew SL; Besser GM; Thakker RV; Huff V
Am J Hum Genet; 1995 Apr; 56(4):944-50. PubMed ID: 7717405
[TBL] [Abstract][Full Text] [Related]
30. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
[TBL] [Abstract][Full Text] [Related]
31. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
32. Fibro-osseous lesions of the craniofacial bones: β-catenin immunohistochemical analysis and CTNNB1 and APC mutation analysis.
E Horvai A; C Jordan R
Head Neck Pathol; 2014; 8(3):291-7. PubMed ID: 24664543
[TBL] [Abstract][Full Text] [Related]
33. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
[TBL] [Abstract][Full Text] [Related]
34. Benign polypoid adenomyomatous endometrium associated with hpt-JT syndrome: a case report.
Arfi A; Chabbert-Buffet N; Boudy AS; de Foucher T; Owen C; Bendifallah S; Darai E
Gynecol Endocrinol; 2020 Jan; 36(1):30-32. PubMed ID: 31429335
[TBL] [Abstract][Full Text] [Related]
35. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.
Haven CJ; Wong FK; van Dam EW; van der Juijt R; van Asperen C; Jansen J; Rosenberg C; de Wit M; Roijers J; Hoppener J; Lips CJ; Larsson C; Teh BT; Morreau H
J Clin Endocrinol Metab; 2000 Apr; 85(4):1449-54. PubMed ID: 10770180
[TBL] [Abstract][Full Text] [Related]
36. A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.
Chiofalo MG; Sparaneo A; Chetta M; Franco R; Baorda F; Cinque L; Granatiero M; D'Agruma L; Pezzullo L; Scillitani A; Guarnieri V
Cell Oncol (Dordr); 2014 Aug; 37(4):281-8. PubMed ID: 25113791
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of benign fibro-osseous lesions of the jaws: a current review for the dental clinician.
Mainville GN; Turgeon DP; Kauzman A
Oral Dis; 2017 May; 23(4):440-450. PubMed ID: 27387498
[TBL] [Abstract][Full Text] [Related]
38. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
39. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
[TBL] [Abstract][Full Text] [Related]
40. Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.
Suster D; Miller JA; Pihan G; Mackinnon AC; Suster S
Mod Pathol; 2021 Oct; 34(10):1831-1838. PubMed ID: 34135467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
